In order to assure the future of rare disease research, training the next generation of early-stage investigators is key. Our consortium offers both fellowship and grant funding opportunities.
2021 Biomarker Development/Validation Program
Opportunity Type: Pilot Grants and Other Requests for Applications
Goal: Support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]).
Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | ALS Association
Eligibility Criteria: Any individual with the requisite scientific training, irrespective of country of residence or origin. Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.
Clinical Research Training Scholarship in ALS and Related Disorders
Opportunity Type: Education and Career Development
Goal: This award aims to support young investigators engaged in clinical research focused on ALS, ALS-FTD, PLS, PMA, and HSP.
Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | American Brain Foundation
Eligibility Criteria: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.
